# ASPirin Intervention for the REDuction of Colorectal Cancer Risk

> **NCT02394769** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 180 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo for Aspirin

## Key facts

- **NCT ID:** NCT02394769
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-07-06
- **Primary completion:** 2019-04-11
- **Final completion:** 2029-07
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02394769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02394769, "ASPirin Intervention for the REDuction of Colorectal Cancer Risk". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02394769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*